AUERBACH ALAN H (PRESIDENT AND CEO) sold 0.7% of their position (47.17K shares) of PUMA BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $166.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/10/2025ACC: 0001437749-25-022547
DirectorOfficer10% Owner· PRESIDENT AND CEO
Since Jul 2018
-47.17K
Net shares
Net seller
$166.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
47.17K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−25.59K
Price / share
$3.53
Trade value
$90.42K
% of position
0.4%
7/8/2025
7.23M→7.20M
Common Stock
Direct
Shares
−21.58K
Price / share
$3.54
Trade value
$76.29K
% of position
0.3%
7/9/2025
7.20M→7.18M
Total
Net shares
−47.17K
Net value
-$166.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/8/2025 | S · Sale | −25.59K | $3.53 | $90.42K | 0.4% | 7.23M | 7.20M |
| Common Stock Direct | 7/9/2025 | S · Sale | −21.58K | $3.54 | $76.29K | 0.3% | 7.20M | 7.18M |
| Total | −47.17K | -$166.70K | ||||||
Derivative Transactions0
No derivative transactions reported